US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.2581
  • -0.0658-20.31%
Close Apr 4 16:00 ET
  • 0.2600
  • +0.0019+0.74%
Post 19:59 ET
66.39MMarket Cap-0.86P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
195.34%178.03M
1,294.81%3.22M
458.83%40.9M
2,399.63%128.23M
-88.07%5.68M
122.05%60.28M
-97.91%231K
4.45%7.32M
-7.37%5.13M
1,231.50%47.6M
Operating revenue
195.34%178.03M
1,294.81%3.22M
458.83%40.9M
2,399.63%128.23M
-88.07%5.68M
122.05%60.28M
-97.91%231K
4.45%7.32M
-7.37%5.13M
1,231.50%47.6M
Cost of revenue
70K
0
Gross profit
195.22%177.96M
122.05%60.28M
Operating expense
16.16%230.37M
20.43%60.32M
3.02%55.58M
18.97%59.53M
24.18%54.94M
3.77%198.32M
30.88%50.09M
7.91%53.95M
1.52%50.04M
-17.39%44.24M
Selling and administrative expenses
13.23%81.31M
25.71%21.22M
31.63%21.28M
-4.93%19.08M
5.55%19.73M
13.29%71.81M
10.91%16.88M
-3.87%16.16M
37.96%20.07M
11.25%18.69M
-Selling and marketing expense
--506K
----
----
----
----
--0
----
----
----
----
-General and administrative expense
12.53%80.81M
22.71%20.71M
31.63%21.28M
-4.93%19.08M
5.55%19.73M
13.29%71.81M
10.91%16.88M
-3.87%16.16M
37.96%20.07M
11.25%18.69M
Research and development costs
17.83%149.06M
17.75%39.1M
-9.22%34.3M
34.98%40.45M
37.81%35.21M
-0.95%126.51M
44.06%33.21M
13.88%37.79M
-13.74%29.97M
-30.49%25.55M
Operating profit
62.03%-52.41M
-14.67%-57.17M
68.52%-14.68M
252.98%68.7M
-1,566.54%-49.26M
15.81%-138.04M
-83.01%-49.86M
-8.47%-46.63M
-2.64%-44.91M
106.72%3.36M
Net non-operating interest income expense
-45.54%3.25M
-95.86%66K
-54.07%987K
-44.91%850K
98.96%1.35M
286.77%5.96M
205.16%1.6M
563.27%2.15M
332.21%1.54M
100.00%676K
Non-operating interest income
10.60%6.6M
11.47%1.78M
-2.47%2.1M
-10.82%1.38M
98.96%1.35M
286.77%5.96M
205.16%1.6M
563.27%2.15M
332.21%1.54M
100.00%676K
Non-operating interest expense
--3.35M
--1.71M
--1.11M
--526K
----
--0
--0
--0
--0
----
Other net income (expense)
-192.52%-18.08M
-4,826.52%-15.42M
-619.30%-3.09M
-97.81%497K
97.43%-61K
3,745.34%19.54M
79.64%-313K
-126.16%-430K
3,558.93%22.66M
-19,883.33%-2.37M
Special income (charges)
-180.36%-16.35M
---16.35M
--0
--0
--0
--20.35M
--0
---106K
--22.16M
---1.7M
-Less：Restructuring and merger&acquisition
129.24%5.95M
--5.95M
--0
--0
--0
---20.35M
--0
--106K
---22.16M
--1.7M
-Less:Impairment of capital assets
--10.4M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-113.88%-1.73M
397.44%931K
-854.63%-3.09M
-0.80%497K
90.91%-61K
-50.56%-807K
79.64%-313K
-119.71%-324K
176.49%501K
-5,691.67%-671K
Income before tax
40.25%-67.24M
-49.31%-72.52M
62.63%-16.79M
438.24%70.05M
-2,988.44%-47.98M
30.94%-112.54M
-71.90%-48.57M
-9.49%-44.91M
52.99%-20.71M
103.35%1.66M
Income tax
167.66%3.58M
358.08%1.69M
20.96%831K
-22.65%526K
-15.84%526K
-46.50%1.34M
-166.00%-656K
72.18%687K
44.68%680K
-1.42%625K
Net income
37.81%-70.81M
-54.88%-74.22M
61.37%-17.62M
425.03%69.52M
-4,781.76%-48.5M
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
Net income continuous Operations
37.81%-70.81M
-54.88%-74.22M
61.37%-17.62M
425.03%69.52M
-4,781.76%-48.5M
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
Minority interest income
Net income attributable to the parent company
37.81%-70.81M
-54.88%-74.22M
61.37%-17.62M
425.03%69.52M
-4,781.76%-48.5M
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.81%-70.81M
-54.88%-74.22M
61.37%-17.62M
425.03%69.52M
-4,781.76%-48.5M
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
Basic earnings per share
44.44%-0.3
-74.19%-0.3135
66.67%-0.06
350.00%0.3
-2,970.81%-0.18
47.06%-0.54
0.00%-0.18
25.00%-0.18
60.00%-0.12
102.09%0.0063
Diluted earnings per share
44.44%-0.3
-74.19%-0.3135
66.67%-0.06
300.00%0.24
-2,996.68%-0.18
47.06%-0.54
0.00%-0.18
25.00%-0.18
60.00%-0.12
102.07%0.0062
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 195.34%178.03M1,294.81%3.22M458.83%40.9M2,399.63%128.23M-88.07%5.68M122.05%60.28M-97.91%231K4.45%7.32M-7.37%5.13M1,231.50%47.6M
Operating revenue 195.34%178.03M1,294.81%3.22M458.83%40.9M2,399.63%128.23M-88.07%5.68M122.05%60.28M-97.91%231K4.45%7.32M-7.37%5.13M1,231.50%47.6M
Cost of revenue 70K0
Gross profit 195.22%177.96M122.05%60.28M
Operating expense 16.16%230.37M20.43%60.32M3.02%55.58M18.97%59.53M24.18%54.94M3.77%198.32M30.88%50.09M7.91%53.95M1.52%50.04M-17.39%44.24M
Selling and administrative expenses 13.23%81.31M25.71%21.22M31.63%21.28M-4.93%19.08M5.55%19.73M13.29%71.81M10.91%16.88M-3.87%16.16M37.96%20.07M11.25%18.69M
-Selling and marketing expense --506K------------------0----------------
-General and administrative expense 12.53%80.81M22.71%20.71M31.63%21.28M-4.93%19.08M5.55%19.73M13.29%71.81M10.91%16.88M-3.87%16.16M37.96%20.07M11.25%18.69M
Research and development costs 17.83%149.06M17.75%39.1M-9.22%34.3M34.98%40.45M37.81%35.21M-0.95%126.51M44.06%33.21M13.88%37.79M-13.74%29.97M-30.49%25.55M
Operating profit 62.03%-52.41M-14.67%-57.17M68.52%-14.68M252.98%68.7M-1,566.54%-49.26M15.81%-138.04M-83.01%-49.86M-8.47%-46.63M-2.64%-44.91M106.72%3.36M
Net non-operating interest income expense -45.54%3.25M-95.86%66K-54.07%987K-44.91%850K98.96%1.35M286.77%5.96M205.16%1.6M563.27%2.15M332.21%1.54M100.00%676K
Non-operating interest income 10.60%6.6M11.47%1.78M-2.47%2.1M-10.82%1.38M98.96%1.35M286.77%5.96M205.16%1.6M563.27%2.15M332.21%1.54M100.00%676K
Non-operating interest expense --3.35M--1.71M--1.11M--526K------0--0--0--0----
Other net income (expense) -192.52%-18.08M-4,826.52%-15.42M-619.30%-3.09M-97.81%497K97.43%-61K3,745.34%19.54M79.64%-313K-126.16%-430K3,558.93%22.66M-19,883.33%-2.37M
Special income (charges) -180.36%-16.35M---16.35M--0--0--0--20.35M--0---106K--22.16M---1.7M
-Less：Restructuring and merger&acquisition 129.24%5.95M--5.95M--0--0--0---20.35M--0--106K---22.16M--1.7M
-Less:Impairment of capital assets --10.4M------------------0----------------
Other non- operating income (expenses) -113.88%-1.73M397.44%931K-854.63%-3.09M-0.80%497K90.91%-61K-50.56%-807K79.64%-313K-119.71%-324K176.49%501K-5,691.67%-671K
Income before tax 40.25%-67.24M-49.31%-72.52M62.63%-16.79M438.24%70.05M-2,988.44%-47.98M30.94%-112.54M-71.90%-48.57M-9.49%-44.91M52.99%-20.71M103.35%1.66M
Income tax 167.66%3.58M358.08%1.69M20.96%831K-22.65%526K-15.84%526K-46.50%1.34M-166.00%-656K72.18%687K44.68%680K-1.42%625K
Net income 37.81%-70.81M-54.88%-74.22M61.37%-17.62M425.03%69.52M-4,781.76%-48.5M31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M
Net income continuous Operations 37.81%-70.81M-54.88%-74.22M61.37%-17.62M425.03%69.52M-4,781.76%-48.5M31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M
Minority interest income
Net income attributable to the parent company 37.81%-70.81M-54.88%-74.22M61.37%-17.62M425.03%69.52M-4,781.76%-48.5M31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.81%-70.81M-54.88%-74.22M61.37%-17.62M425.03%69.52M-4,781.76%-48.5M31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M
Basic earnings per share 44.44%-0.3-74.19%-0.313566.67%-0.06350.00%0.3-2,970.81%-0.1847.06%-0.540.00%-0.1825.00%-0.1860.00%-0.12102.09%0.0063
Diluted earnings per share 44.44%-0.3-74.19%-0.313566.67%-0.06300.00%0.24-2,996.68%-0.1847.06%-0.540.00%-0.1825.00%-0.1860.00%-0.12102.07%0.0062
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.98%
Sample Name
Sample Code
 +29.93%
Sample Name
Sample Code
 +20.30%
4
Shanghai Menon Animal Nutrition Technology
301156
+20.03%
5
Nanjing Railway New Technology
301016
+20.02%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 605.550
Sample Name
Sample Code
 147.740
Sample Name
Sample Code
 145.600
4
Microsoft
MSFT
359.840
5
Amazon
AMZN
171.000
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 2.015
Sample Name
Sample Code
 11.300
Sample Name
Sample Code
 0.3345
4
CleanSpark
CLSK
7.320
5
IREN Ltd
IREN
5.940
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -